Skip to content

Influence of Implants and Locators for Improved Retention

Influence of Implants and Locators for Improved Retention of Mandibular Full Dentures on Patient's Quality of Life and Oral Function. A Controlled, Randomized and Prospective Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02551146
Acronym
GC
Enrollment
14
Registered
2015-09-16
Start date
2015-09-07
Completion date
2018-05-17
Last updated
2022-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mouth, Edentulous

Brief summary

The aim of this study is to assess the influence of this particular treatment method on the patients' quality of life and masticatory function.

Detailed description

For this prospective randomized controlled clinical trial patients with edentulous mandibles and tissue supported (full) dentures were treated with 2 dental implants and locators in order to improve prosthesis stability. The LOCATOR System is comprised of three parts: The LOCATOR implant attachment (LOCATOR abutment), the LOCATOR Male and the LOCATOR Denture Cap. The abutment is inserted directly into the implant using a torque wrench, while the Denture Cap is placed into the base of the overdenture for polymerization using acrylic resin. Custom retention is achieved via LOCATOR Males - small color-coded (according to retention force) plastic inserts - which can be exchanged as needed.

Interventions

DEVICEA Locator with retention elements

Insertion of GC Pilier locator abutments with retention elements

DEVICEB Locator without retention elements

Insertion of GC Pilier locator abutments without retention elements

Sponsors

Philipps University Marburg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* age 45-80 years (male or female) * sufficient full dentures in the mandible * must be able to clean their teeth on their own * edentulous mandible with interforaminal adequate bone for insertion of implants * implantation sites free of infections and root fragments * no need for treatment of the maxillary teeth * Written Informed Consent

Exclusion criteria

* systemic diseases * mental disability that may affect the participant's ability to properly follow study instructions * oral mucosal diseases * long-term medication with steroids, bisphosphonates * known allergic reactions to dental materials * malignant tumor in the head and neck area * requirement of any concurrent radiotherapy or chemotherapy or any radiotherapy or chemotherapy within the last 10 years pregnancy or breastfeeding at study entry

Design outcomes

Primary

MeasureTime frameDescription
Quality of life (OHIP-G-49)3 months after randomizationThe oral health-related quality of life is assessed by the German version of the Oral Health Impact Profile questionnaire (OHIP-G-49, Locker et al 1993)

Secondary

MeasureTime frameDescription
Plaque index3 months (T0), 6 months (T1), 9 months (T2), 12 months (T3)The Plaque index (Silness and Loe 1964) will be assessed and the change from baseline will be documented.
Probing pocket depth3 months (T0), 6 months (T1), 9 months (T2), 12 months (T3)The Probing pocket depth with bleeding on probing (6 sites of every tooth and implant) will be assessed and the change from baseline will be documented.
Gingival index3 months (T0), 6 months (T1), 9 months (T2), 12 months (T3)The Gingival index (Loe and Silness 1963) will be assessed and the change from baseline will be documented.
masticatory function3 months (T0), 6 months (T1), 9 months (T2), 12 months (T3)Video documentation of chewing a defined bolus. After chewing a defined bolus for 10 seconds comparison of reduction ratio of the bolus is documented by photography and the change from baseline will be documented.
Mucosal recessions3 months (T0), 6 months (T1), 9 months (T2), 12 months (T3)The mucosal recessions at implants will be assessed and the change from baseline will be documented.
width of keratinized gingiva/mucosa3 months (T0), 6 months (T1), 9 months (T2), 12 months (T3)The width of keratinized gingiva/mucosa will be assessed and the change from baseline will be documented.
intraoral photo-documentation3 months (T0), 6 months (T1), 9 months (T2), 12 months (T3)A photo-documentation (intraoral) will be done to assess the changes from baseline.
Gingival recessions3 months (T0), 6 months (T1), 9 months (T2), 12 months (T3)The Gingival recessions at teeth will be assessed and the change from baseline will be documented.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026